Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report)’s share price gapped up before the market opened on Monday after HC ...

In a report released yesterday, Judah Frommer from Morgan Stanley maintained a Buy rating on Bicara Therapeutics Inc. (BCAX – Research Report), ...

H.C. Wainwright analyst Robert Burns has reiterated their bullish stance on BCAX stock, giving a Buy rating on January 22.Invest with ...

BOSTON - Bicara Therapeutics Inc. (NASDAQ:BCAX), a clinical-stage biotech company with a market capitalization of $631 ...

Bicara Therapeutics (NASDAQ:BCAX – Get Free Report) had its target price hoisted by equities researchers at HC Wainwright ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal ...

The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging population, which boosts demand for ...

umin.ac.jp Backgroud: Idiopathic pulmonary fibrosis is a devastating disorder for which there is no effective treatment. Transforming growth factor (TGF)-β plays a critical role in provoking fibrosis.

Cytokines are proteins, peptides or glycoproteins secreted by lymphocytes and monocytes that regulate immune responses, haematopoiesis and lymphocyte development. Cytokines include interleukins ...

Apple Intelligence has been the focus of most iOS 18 updates so far, and we’re still waiting on the big Siri overhaul that adds personal context using the data on your phone and scores of new ...

It is likely that cytokines, in particular TNF, and also TGF and many others, may be critically involved in driving the inflammatory process leading to production of MMPs and cartilage and bone ...